CN102406646B - Arylurea derivatives is for the preparation of the purposes for the treatment of transplant rejection medicine - Google Patents
Arylurea derivatives is for the preparation of the purposes for the treatment of transplant rejection medicine Download PDFInfo
- Publication number
- CN102406646B CN102406646B CN201010288825.XA CN201010288825A CN102406646B CN 102406646 B CN102406646 B CN 102406646B CN 201010288825 A CN201010288825 A CN 201010288825A CN 102406646 B CN102406646 B CN 102406646B
- Authority
- CN
- China
- Prior art keywords
- rejection
- transplant rejection
- preparation
- medicine
- transplant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010288825.XA CN102406646B (en) | 2010-09-20 | 2010-09-20 | Arylurea derivatives is for the preparation of the purposes for the treatment of transplant rejection medicine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010288825.XA CN102406646B (en) | 2010-09-20 | 2010-09-20 | Arylurea derivatives is for the preparation of the purposes for the treatment of transplant rejection medicine |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102406646A CN102406646A (en) | 2012-04-11 |
CN102406646B true CN102406646B (en) | 2015-09-09 |
Family
ID=45909186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010288825.XA Expired - Fee Related CN102406646B (en) | 2010-09-20 | 2010-09-20 | Arylurea derivatives is for the preparation of the purposes for the treatment of transplant rejection medicine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102406646B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2016283105C1 (en) * | 2015-06-26 | 2023-02-02 | Dana-Farber Cancer Institute, Inc. | 4,6-pyrimidinylene derivatives and uses thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1764645A (en) * | 2003-03-24 | 2006-04-26 | 默克专利有限公司 | Oxamide derivatives useful as raf-kinase inhibitors. |
CN101263142A (en) * | 2005-05-20 | 2008-09-10 | 阿雷生物药品公司 | RAF inhibitor compounds and methods of use thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200804349A (en) * | 2005-12-23 | 2008-01-16 | Kalypsys Inc | Novel substituted pyrimidinyloxy ureas as inhibitors of protein kinases |
CL2008001933A1 (en) * | 2007-06-29 | 2009-09-25 | Millennium Pharm Inc | Pyrimidine derived compounds, raph kinase inhibitors; intermediate compounds; preparation procedure; pharmaceutical composition; and its use to treat proliferative, cardiac, neurodegenerative, inflammatory, bone, immunological, viral disease, among others. |
-
2010
- 2010-09-20 CN CN201010288825.XA patent/CN102406646B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1764645A (en) * | 2003-03-24 | 2006-04-26 | 默克专利有限公司 | Oxamide derivatives useful as raf-kinase inhibitors. |
CN101263142A (en) * | 2005-05-20 | 2008-09-10 | 阿雷生物药品公司 | RAF inhibitor compounds and methods of use thereof |
Also Published As
Publication number | Publication date |
---|---|
CN102406646A (en) | 2012-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6469877B2 (en) | Pharmaceutical composition for inhibiting growth of cancer stem cells, comprising an aldehyde inhibitor and a biguanide compound | |
CN105232532A (en) | Vitamin C and vitamin K, and compositions and application thereof | |
US20190262267A1 (en) | Pharmaceutical solution having a toxicity-reducing effect for antitumor drugs, and pharmaceutical composition comprising same | |
CN108498497B (en) | Pharmaceutical composition for treating kidney cancer and application thereof | |
US20080118482A1 (en) | Treating mouth ulcer with live bacteria | |
CN101123965B (en) | Methylphenidate derivatives and uses of methylphenidate derivatives | |
WO2007036113A1 (en) | Medical use of periplocoside a and e | |
CN102406646B (en) | Arylurea derivatives is for the preparation of the purposes for the treatment of transplant rejection medicine | |
CN104688789A (en) | Papaya seed extract sustained-release preparation and application thereof | |
CN106146558A (en) | New oxazolidinones and preparation method thereof | |
CN102406644A (en) | New use of aryl urea derivative in preparation of medicine for treating transplant rejection | |
JPS6379824A (en) | Carcinostatic agent | |
CN113855689B (en) | Application of engeletin or isomer thereof in preparation of medicine for treating endometriosis | |
CN112168826B (en) | Application of daresbuvir in preparation of anti-esophageal cancer and gastric cancer tumor medicines | |
WO2000078295A1 (en) | Microencapsulated bovine adrenal medulla chromaffin cell-drug for alleviating pain | |
CN102626411A (en) | Pharmaceutical composition containing propofol and opioid analgesics and use thereof | |
CN113425710A (en) | Application of chlorogenic acid in preparing medicine for treating central nervous system tumor | |
CN101365452A (en) | Methods and compositions for the treatment of vascular disease | |
CN101210021A (en) | Cephalosporin compounds | |
CN101190935B (en) | Compound used for viral infect | |
WO2022060079A1 (en) | Pharmaceutical composition for preventing or treating graft versus host disease comprising thiamine derivatives | |
CN105193810B (en) | 5 fluorouracil compositions and its application in antitumor injection is prepared | |
CN101190913A (en) | Novel compound with antiviral activity | |
AU2016340769B2 (en) | Composition for treatment of infertility in a female subject | |
JP2008044905A (en) | Composition for treating solid neoplasm and use of the composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 100871, Beijing, Haidian District Cheng Fu Road 298, founder building, 9 floor Patentee after: PEKING UNIVERSITY FOUNDER GROUP Co.,Ltd. Patentee after: PKUCARE PHARMACEUTICAL R&D CENTER Patentee after: PKU HEALTHCARE INDUSTRY Group Address before: 100871 No. 298, Fu Cheng Road, Beijing, Haidian District Patentee before: PEKING UNIVERSITY FOUNDER GROUP Co.,Ltd. Patentee before: PKUCARE PHARMACEUTICAL R&D CENTER Patentee before: Pku Healthcare Industry Group Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221026 Address after: 3007, Hengqin international financial center building, No. 58, Huajin street, Hengqin new area, Zhuhai, Guangdong 519031 Patentee after: New founder holdings development Co.,Ltd. Patentee after: PKUCARE PHARMACEUTICAL R&D CENTER Patentee after: Peking University Medical Management Co.,Ltd. Address before: 100871, Beijing, Haidian District Cheng Fu Road 298, founder building, 9 floor Patentee before: PEKING UNIVERSITY FOUNDER GROUP Co.,Ltd. Patentee before: PKUCARE PHARMACEUTICAL R&D CENTER Patentee before: PKU HEALTHCARE INDUSTRY Group |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150909 |
|
CF01 | Termination of patent right due to non-payment of annual fee |